$--
(Market cap
$809 Mln
Revenue (TTM)
$182 Mln
P/E Ratio
64.5
P/B Ratio
3.4
Div. Yield
1.9 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
0.1 %
-
ROCE
-- %
-
Industry P/E
50.52
-
EV/EBITDA
26.7
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$6.3
-
Face value
--
-
Shares outstanding
1,759,950
10 Years Aggregate
CFO
$368.60 Mln
EBITDA
$418.91 Mln
Net Profit
$311.51 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
ATRION Corporation (ATRI)
| 21.4 | 0.4 | -0.1 | -3.1 | -13.1 | -9.9 | 3.7 |
|
BSE Sensex*
| -9.3 | 2.0 | 0.1 | -5.7 | 6.6 | 8.0 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|---|---|---|---|---|---|---|---|
|
ATRION Corporation (ATRI)
| -32.3 | -20.6 | 10.9 | -13.6 | 2.2 | 18.3 | 25.3 |
|
S&P Small-Cap 600
| 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 | 11.7 |
|
BSE Sensex
| 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
ATRION Corporation (ATRI)
|
459.9 | 809.4 | 181.6 | 12.6 | 6.0 | 5.2 | 64.5 | 3.4 |
| 0.4 | 94.9 | 9.9 | -83.8 | -721.2 | -- | -- | 7.1 |
Shareholding Pattern
View DetailsAbout ATRION Corporation (ATRI)
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery... products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas. Read more
-
Executive Chairman
Mr. Emile A. Battat
-
Executive Chairman
Mr. Emile A. Battat
-
Headquarters
Allen, TX
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for ATRION Corporation (ATRI)
What is the current share price of ATRION Corporation (ATRI) Today?
The share price of ATRION Corporation (ATRI) is $459.92 (NASDAQ) as of 30-Aug-2024 09:30 EDT. ATRION Corporation (ATRI) has given a return of -13.15% in the last 3 years.
What is the current PB & PE ratio of ATRION Corporation (ATRI)?
The P/E ratio of ATRION Corporation (ATRI) is 64.50 times as on 30-Aug-2024, a 28 premium to its peers’ median range of 50.52 times.
The P/B ratio of ATRION Corporation (ATRI) is 3.39 times as on 30-Aug-2024, a 1 premium to its peers’ median range of 3.37 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2023
|
39.03
|
3.12
|
|
2022
|
31.96
|
4.67
|
|
2021
|
42.65
|
5.77
|
|
2020
|
40.00
|
5.34
|
|
2019
|
40.89
|
6.32
|
What is the 52 Week High and Low of ATRION Corporation (ATRI)?
The 52-week high and low of ATRION Corporation (ATRI) are Rs -- and Rs -- as of 21-Jun-2026.
What is the market cap of ATRION Corporation (ATRI)?
ATRION Corporation (ATRI) has a market capitalisation of $ 809 Mln as on 30-Aug-2024. As per SEBI classification, it is a Small Cap company.
Should I invest in ATRION Corporation (ATRI)?
Before investing in ATRION Corporation (ATRI), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.